Top

Published in:

Open Access 01-12-2024 | COVID-19 | Research

Characteristics and outcomes of a hospitalized cohort with reduced mortality from COVID-19, White Mountain apache tribal lands, April 1 – July 31, 2020

Authors: Ryan M. Close, Chelsea S. Lutz, T. Shaifer Jones, Myles Stone, Nicole Bratsch, Trevor Thompson, Christopher Jentoft, James B. McAuley

Published in: BMC Public Health | Issue 1/2024

Abstract

Background

Widespread transmission of COVID-19 continues to threaten public health, particularly of rural, American Indian communities. Although COVID-19 risk factors for severe disease and clinical characteristics are well described in the general population, there has been little shared on hospitalized American Indian populations.

Methods

In this observational study, we performed chart extractions on all persons hospitalized with COVID-19 from April 1 through July 31, 2020 among an exclusively American Indian population living on or near Tribal lands in eastern Arizona. We provide descriptive statistics for the cohort stratified by presentation, comparing those who self-presented or were referred by an outreach program. Exploratory analyses were performed to identify risk factors for morbidity and mortality.

Results

During the observation period, 2262 persons were diagnosed with COVID-19 and 490 (22%) were hospitalized. Hospitalized persons had a median age of 54 years; 92% had at least one comorbidity, 72% had greater than one comorbidity, and 60% had a BMI of > 30. Most persons required supplemental oxygen (83%), but the majority (62%) only required nasal cannula and only 11% were intubated. The case fatality rates were 1.7% for the population, 7.1% among hospitalizations, and 9.3% among hospitalized patients 50 years and older. All rates that are significantly lower than those reported nationally during the same period.

Conclusions

We observed a cohort of American Indian patients hospitalized secondary to COVID-19 with greater number of comorbidities compared to the general population but with lower mortality rates. We posit that the primary driver of mortality reduction for this population and the hospitalized cohort was a community-based referral program that led to disproportionately lower fatality rates among the oldest persons.

Available only for authorised users

Hatcher SM, Agnew-Brune C, Anderson M, et al. COVID-19 among American Indian and Alaska native persons - 23 states, January 31-July 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(34):1166–9. https://doi.org/10.15585/mmwr.mm6934e1.CrossRefPubMedPubMedCentral

Arrazola J, Masiello MM, Joshi S, et al. COVID-19 mortality among American Indian and Alaska native persons — 14 states, January–June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(49):1853–6. https://doi.org/10.15585/mmwr.mm6949a3.CrossRefPubMedPubMedCentral

Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5. https://doi.org/10.1016/j.ijid.2020.03.017.CrossRefPubMedPubMedCentral

Hernández-Galdamez DR, González-Block MÁ, Romo-Dueñas DK, et al. Increased risk of hospitalization and death in patients with COVID-19 and pre-existing noncommunicable diseases and modifiable risk factors in Mexico. Arch Med Res. 2020;51(7):683–9. https://doi.org/10.1016/j.arcmed.2020.07.003.CrossRefPubMedPubMedCentral

Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–81. https://doi.org/10.1001/jama.2020.5394.CrossRefPubMedPubMedCentral

Reilev M, Kristensen KB, Pottegård A, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020;49(5):1468–81. https://doi.org/10.1093/ije/dyaa140.CrossRefPubMedPubMedCentral

Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9. https://doi.org/10.1001/jama.2020.1585.CrossRefPubMedPubMedCentral

Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. https://doi.org/10.1056/NEJMoa2002032.CrossRefPubMed

Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–6. https://doi.org/10.1038/s41586-020-2521-4.CrossRefPubMedPubMedCentral

10.

Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in new York City: prospective cohort study. BMJ. 2020;369:m1966. https://doi.org/10.1136/bmj.m1966.CrossRefPubMedPubMedCentral

11.

Zelner J, Trangucci R, Naraharisetti R, et al. Racial disparities in coronavirus disease 2019 (COVID-19) mortality are driven by unequal infection risks. Clin Infect Dis. 2021;72(5):e88–95. https://doi.org/10.1093/cid/ciaa1723.CrossRefPubMed

12.

Ogedegbe G, Ravenell J, Adhikari S, et al. Assessment of racial/ethnic disparities in hospitalization and mortality in patients with COVID-19 in new York City. JAMA Netw Open. 2020;3(12):e2026881–1. https://doi.org/10.1001/jamanetworkopen.2020.26881.CrossRefPubMedPubMedCentral

13.

Webb Hooper M, Nápoles AM, Pérez-Stable EJ. COVID-19 and racial/ethnic disparities. JAMA. 2020;323(24):2466–7. https://doi.org/10.1001/jama.2020.8598.CrossRefPubMedPubMedCentral

14.

Woodcock J, Araojo R, Thompson T, Puckrein GA. Integrating research into community practice — toward increased diversity in clinical trials. N Engl J Med. 2021;385(15):1351–3. https://doi.org/10.1056/NEJMp2107331.CrossRefPubMed

15.

Stone MJ, Close RM, Jentoft CK, et al. High-risk outreach for COVID-19 mortality reduction in an indigenous community. Am J Public Health Published. 2021;14:e1–3. https://doi.org/10.2105/AJPH.2021.306472.CrossRef

16.

Close RM, et al. Innovative and integrated contact tracing: Indian Health Service, Arizona, December 2020-January 2021. Public Health Rep. 2022;137(2_suppl):51S–5S.CrossRefPubMedPubMedCentral

17.

AZDHS COVID-19 Data. Arizona Department of Health Services. Published October 16, 2021. https://www.azdhs.gov/covid19/data/index.php. Accessed 16 Oct 2021

18.

Navajo Nation COVID-19 Dashboard. Navajo Department of Health. Published October 15, 2021. ndoh.navajo-nsn.gov/COVID-19/Data. Accessed 15 Oct 2021

19.

Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 — final report. N Engl J Med. 2020;383(19):1813–26. https://doi.org/10.1056/NEJMoa2007764.CrossRefPubMed

20.

Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369:m1985. https://doi.org/10.1136/bmj.m1985.CrossRefPubMedPubMedCentral

21.

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. https://doi.org/10.1016/S0140-6736(20)30566-3.CrossRefPubMedPubMedCentral

22.

Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area. JAMA. 2020;323(20):2052–9. https://doi.org/10.1001/jama.2020.6775.CrossRefPubMedPubMedCentral

23.

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–93. https://doi.org/10.1001/jama.2020.12839.CrossRefPubMed

24.

Centers for disease Control and Prevention (2023). In-hospital Mortality Among Hospital Confirmed COVID-19 Encounters by Week From Selected Hospitals. National Center for Health Statistics. https://www.cdc.gov/nchs/covid19/nhcs/hospital-mortality-by-week.htm. Accessed 28 Nov 2023

25.

Thompson CN, Baumgartner J, Pichardo C, et al. COVID-19 outbreak - new York City, February 29-June 1, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(46):1725–9. https://doi.org/10.15585/mmwr.mm6946a2.CrossRefPubMedPubMedCentral

26.

Odone A, Delmonte D, Scognamiglio T, Signorelli C. COVID-19 deaths in Lombardy, Italy: data in context. Lancet Public Health. 2020;5(6):e310. https://doi.org/10.1016/S2468-2667(20)30099-2.CrossRefPubMedPubMedCentral

27.

Close RM, Stone MJ. Contact tracing for native Americans in rural Arizona. N Engl J Med. 2020;383(3):e15. https://doi.org/10.1056/NEJMc2023540.CrossRefPubMed

28.

Chelsea Curtis. “I’m so glad that I’m alive today”: robust contact tracing is saving lives of apache tribal members. AZCentral Published October 18, 2020. https://www.azcentral.com/story/news/local/arizona-health/2020/10/18/robust-contact-tracing-saving-lives-apache-tribal-members-coronavirus/5712555002/. Accessed 16 Oct 2021

29.

Kalil AC, et al. Baricitinib plus Remdesivir for hospitalized adults with Covid-19. N Engl J Med. 2020;384(9):795–807.CrossRefPubMed

30.

Health, United States, 2015: With special feature on racial and ethnic health disparities. US Department of Health and Human Services; 2016. www.cdc.gov/nchs/data/hus/hus15.pdf. Accessed 8 Jul 2021

31.

Tartof SY, Qian L, Hong V, et al. Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization. Ann Intern Med. 2020;173(10):773–81. https://doi.org/10.7326/M20-3742.CrossRefPubMed

32.

Anderson MR, Geleris J, Anderson DR, et al. Body mass index and risk for intubation or death in SARS-CoV-2 infection: a retrospective cohort study. Ann Intern Med. 2020;173(10):782–90. https://doi.org/10.7326/M20-3214.CrossRefPubMed

33.

Tsai H, Lee J, Hedlin H, Zamanian RT, de Jesus Perez VA. Methamphetamine use association with pulmonary diseases: a retrospective investigation of hospital discharges in California from 2005 to 2011. ERJ Open Res. 2019;5(4):00017–2019. https://doi.org/10.1183/23120541.00017-2019.CrossRefPubMedPubMedCentral

34.

Hossain MK, Hassanzadeganroudsari M, Apostolopoulos V. Why METH users are at high risk of fatality due to COVID-19 infection? Expert Rev Vaccines. 2020;19(12):1101–3. https://doi.org/10.1080/14760584.2020.1858059.CrossRefPubMed

35.

Testino G. Are patients with alcohol use disorders at increased risk for Covid-19 infection? Alcohol Alcohol. 2020;55(4):344–6. https://doi.org/10.1093/alcalc/agaa037.CrossRefPubMed

36.

Simou E, Britton J, Leonardi-Bee J. Alcohol and the risk of pneumonia: a systematic review and meta-analysis. BMJ Open. 2018;8(8):e022344. https://doi.org/10.1136/bmjopen-2018-022344.CrossRefPubMedPubMedCentral

37.

Happel KI, Nelson S. Alcohol, immunosuppression, and the lung. Proc Am Thorac Soc. 2005;2(5):428–32. https://doi.org/10.1513/pats.200507-065JS.CrossRefPubMed

38.

Whitesell NR, Beals J, Crow CB, Mitchell CM, Novins DK. Epidemiology and etiology of substance use among American Indians and Alaska natives: risk, protection, and implications for prevention. Am J Drug Alcohol Abuse. 2012;38(5):376–82. https://doi.org/10.3109/00952990.2012.694527.CrossRefPubMedPubMedCentral

39.

Close R, Enos L. Indian Health Service Community Health ECHO Session: case investigation and contact tracing. Presentation presented at the: Project ECHO. University of New Mexico; 2021.

40.

Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 — COVID-NET, 14 states, march 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–64. https://doi.org/10.15585/mmwr.mm6915e3.CrossRefPubMedPubMedCentral

Title: Characteristics and outcomes of a hospitalized cohort with reduced mortality from COVID-19, White Mountain apache tribal lands, April 1 – July 31, 2020
Authors: Ryan M. Close
Chelsea S. Lutz
T. Shaifer Jones
Myles Stone
Nicole Bratsch
Trevor Thompson
Christopher Jentoft
James B. McAuley
Publication date: 01-12-2024
Publisher: BioMed Central
Keyword: COVID-19
Published in: BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/s12889-024-18098-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Characteristics and outcomes of a hospitalized cohort with reduced mortality from COVID-19, White Mountain apache tribal lands, April 1 – July 31, 2020

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Level of completion of a continuum of age-appropriate infant feeding practices and barriers among breastfeeding mothers in Ethiopia: a mixed methods study

The role of frailty in the relationships between social relationships and health outcomes: a longitudinal study

Associations between cardiovascular diseases and cancer mortality: insights from a retrospective cohort analysis of NHANES data

Prevalence of prediabetes and risk of CVD mortality in individuals with prediabetes alone or plus hypertension in Northeast China: insight from a population based cohort study

How the Plants for Joints multidisciplinary lifestyle intervention achieved its effects: a mixed methods process evaluation

Clusters of lifestyle behavioral risk factors and their associations with depressive symptoms and stress: evidence from students at a university in Finland